Moataz Karmalawy


Moataz Karmalawy is President and Chief Executive Officer of ProNova Solutions, LLC, and Senior Vice President of Provision Healthcare, LLC. Moataz is leading the strategic business development to revolutionize proton therapy in the market with ProNova’s state-of-the art proton therapy solutions and drive innovative partnerships to grow and develop comprehensive cancer care centers.

Moataz has established over 50 global comprehensive cancer centers with some of the world’s most prestigious institutes in North America, Asia and Europe as well as establishing manufacturing facilities and service organizations. He leverages over 25 years in creating significant value globally in healthcare and has cultivated and led high-performance teams during significant change events including acquisitions, post-merger integrations, joint ventures, and new product launches. The roles he has filled include a wide range of business sizes including President of businesses within Fortune 500 companies with full P&L responsibility, and Head of Operations and R&D as well as marketing roles within a Malcolm Baldrige award winning organization. He also founded, managed, sold, and integrated a startup company earlier in his career.

Moataz was previously President of Advanced Oncotherapy for several years. Prior to that, for 12 years, he served as the President of the Worldwide Particle Therapy business at Varian Medical Systems, the world’s market leader of medical devices and software for treating cancer and other medical conditions with radiotherapy, radiosurgery, proton therapy and brachytherapy.

Prior to joining Varian, Moataz worked for ADAC/Philips Medical Systems for 10 years in a variety of roles including Vice President of Research and Development., Vice President of Operations and Vice President of Strategic Development. ADAC was the world market leader in Nuclear Medicine and is a Malcolm Baldrige National Quality Award-winning company. ADAC was acquired by Philips Healthcare, a leading health technology company in diagnostic imaging, image-guided therapy, patient monitoring, and health informatics, as well as in consumer health and home care.

Prior to Philips, Moataz spent 5 years at Park Medical Systems in Montreal, Canada directing their Nuclear Medicine Systems operations. He also founded and managed ACK Controls, a company specializing in the development of fully integrated hardware/software-based solutions for machinery monitoring, diagnosis, and prognosis. Moataz holds over 10 patents and has been published in major technical journals and conference proceedings worldwide.

Moataz holds an MBA, Technology Management, PhD, Master of Engineering, and Bachelor of Engineering from Concordia University, Montreal, Canada and Wharton School of Business, University of Pennsylvania, Octagon Executive Program.

Moataz is a member of several boards including: Founder and Chairman of the Board of Directors for The Alliance for Proton Therapy Access, the Executive Board Member of the SPTC Proton Therapy Center, and a Medical Scientific Board member of Ergea France (

David Liu


David leads Provision’s Asia market strategy and business development. David was a General Partner at Avoda Capital, a Shanghai based healthcare private equity firm and the founder and president of Cherokee Rose Group, a healthcare management consultancy advising clients on Sino-American market entry strategy and investment. David was Vice President and General Manager of McKesson-US Oncology Asia Pacific for nearly 10 years where he developed regional strategy, directed M&A activities, and negotiated partnerships with pharmaceutical and medical technology manufacturers. Prior to McKesson David was COO at, one of the largest global Asian e-commerce companies, backed by Walden Ventures and Morgan Stanley. David has also held senior positions in strategic planning, marketing, and operations at IBM, American Express, and Ernst & Young. He has lectured on start-up strategy and emerging markets private equity at Harvard Business School, The Wharton School and Peking University.

David has an MBA, a Masters’ Degree in Industrial Engineering, and a Bachelors’ of Science Degree in Operations Research from Cornell University.

Tracy Dobbs, MD


Dr. Dobbs is the Chief Medical Officer of Provision Healthcare, LLC and a Medical Oncologist and founder of the largest Medical Oncology group, Tennessee Cancer Specialists, in East Tennessee and the third largest in the state. He has been in practice for 18 years and is director of 3 outlying medical oncology clinics which serve two states. Dr. Dobbs is the Principal Investigator for over twenty open clinical research trials as well as over seventy trials in some state of follow-up.

Dr. Tracy Dobbs earned his medical degree from the University of Missouri. He completed his internship and residency in internal medicine at the University of Oklahoma Health Sciences Center. Dr. Dobbs completed a post-graduate fellowship in medical oncology/hematology at the University of Oklahoma Health Sciences Center. He is board certified in internal medicine and medical oncology. Dr. Dobbs is the Principal Investigator for the majority of protocols offered through Tennessee Cancer Specialists. Dr. Dobbs is a member of the American Cancer Society, the Tennessee Medical Association, the Knoxville Academy of Medicine, the American Society of Clinical Oncologists, the American Medical Association, and the American College of Physicians. He served as Chief of Staff of Baptist Hospital of East Tennessee from 1996-1997 and was Chairman of the Credentials Committee from 1994 to 1995. He was also a member of the Baptist Hospital of East Tennessee Board of Directors from 1993 to 2006 and is currently a member of the American Cancer Society of Knox County Board of Directors.

Mary Lou DuBois


Mary Lou DuBois is President of Provision Health Services, LLC, and Sr. Vice President of Provision Healthcare. She is a Founder and Board Member of Provision Health Partners, LLC (PHP) and ProNova Solutions, LLC. Mary Lou leads the development of comprehensive cancer centers to provide the most advanced treatment and diagnostic solutions for diagnosing and treatment of cancer patients.

From 2014 to 2020, Ms. DuBois led the successful design, development and start-up of three proton therapy centers with two centers being successfully managed from startup to fully operational, reaching and exceeding goal milestones and one center reaching completion of design and development and ready for startup. Ms. DuBois led the development of a “Culture of Care” program that became a distinguishing brand feature of Provision and focuses on each and every patient providing a unique and caring patient experience.

From 2004 to 2013, as President of PHP, Ms. DuBois successfully led the strategic design, development and management of two medical office buildings at Provision Health Alliance in Knoxville, a comprehensive clinical outpatient healthcare center including comprehensive diagnostic imaging, advanced chemotherapy and radiation therapy, a women’s health center, eye surgery center, wellness center, physical therapy, a cyclotron and nuclear pharmacy, and clinical trials and research capabilities. PHP offered management services consisting of Human Resources, IT, Marketing, Accounting, Billing and Facilities management services.

Ms. DuBois was previously employed by CTI Molecular Imaging, Inc. (CTI) from 1986 to 2004 and served in various roles. As Officer and Vice President, Customer Solutions, , she led the customer sales support and product management groups to coordinate the launch and marketing of new technology product releases, and was responsible for coordinating national sales meetings and trade shows at leading industry societies, such as the Radiology Society of North America and Society of Nuclear Medicine.

Ms. DuBois also led an IT development team to develop an internet-based customer solutions strategy and led CTI’s Customer Training Center for PET providers to gain knowledge and entry into the PET market. As Senior Director, Corporate Solutions, she provided leadership for developing and implementing information technology initiatives for internal and external customers, network infrastructure, telecommunications, and support services as well as the implementation of an Enterprise Resource Planning system. Other career experience at CTI included Human Resources, Facilities, and Administrative Services for the company.

Ms. DuBois received her Bachelor’s Degree in Business Management from Tennessee Wesleyan College.

Terry Douglass, Ph.D.


Terry Douglass is the Founder, Chairman of the Board of Directors, and Chief Executive Officer of Provision Healthcare, LLC. He is also the Chairman of Provision Trust, Inc., Provision Foundation, Inc., and Founder and Chairman of the Board of ProNova Solutions, LLC.

Dr. Douglass was Founder and served as the Chairman of the Board of CTI Molecular Imaging, Inc., a public company that specialized in the development, production and distribution of products and services for the medical diagnostic imaging market, from 1983 to 2005 when it was acquired by Siemens at a market capitalization of $1 billion. He also served as President and CEO of CTI Molecular Imaging from its formation in 1983 until 2003. During this tenure, Dr. Douglass played an integral role in the development and commercialization of positron emission tomography (PET) and its development globally, including PET cyclotron technology that now plays a significant role in proton therapy. He was also instrumental in the development of FDA approval for PET and Medicare reimbursement for PET services.

From 1968 to 1983, Dr. Douglass was employed at EG&G Ortec as a design engineer, marketing manager, and division manager and served as CEO and President during the last three years at EG&G Ortec.

Dr. Douglass is currently leading the development of the world-class comprehensive cancer care program for Provision Healthcare at Dowell Springs in Knoxville, Tenn. Dr. Douglass has served or is serving on other boards in addition to the Provision Boards and CTI Boards including the Whitestone Group, Computational Systems, Inc., EPRI, Ionogen, LLC, YMCA, Knoxville Chamber of Commerce, Hope Resource Center, Young Life, Vanderbilt Medical Advisory Board, and the UT Medical Center Biomedical Imaging Foundation.

Dr. Douglass graduated with Bachelor of Science, Masters’ of Science, and Ph.D. degrees in Electrical Engineering from the University of Tennessee.